Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells
Open Access
- 9 February 2010
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (5), 844-851
- https://doi.org/10.1038/sj.bjc.6605561
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Diffuse-Type Gastric Carcinoma: Progression, Angiogenesis, and Transforming Growth Factor β SignalingJNCI Journal of the National Cancer Institute, 2009
- Recent results of therapy for scirrhous gastric cancerSurgery Today, 2009
- Transforming Growth Factor β: Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?Cancer Research, 2008
- ZO-1- and ZO-2-Dependent Integration of Myosin-2 to Epithelial Zonula AdherensMolecular Biology of the Cell, 2008
- TGFβ in CancerCell, 2008
- Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 ActivationThe American Journal of Pathology, 2008
- Cell Contact–dependent Regulation of Epithelial–Myofibroblast Transition via the Rho-Rho Kinase-Phospho-Myosin PathwayMolecular Biology of the Cell, 2007
- Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell lineCancer Science, 2006
- The progression of invasiveness regarding the role of transforming growth factor β receptor type II in gastric cancerEuropean Journal of Surgical Oncology, 2000